Nathaniel Dasyam, Philip George, Robert Weinkove. Br J Clin Pharmacol 2020
Times Cited: 8
Times Cited: 8
Times Cited
Times Co-cited
Similarity
Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.
G Gross, T Waks, Z Eshhar. Proc Natl Acad Sci U S A 1989
G Gross, T Waks, Z Eshhar. Proc Natl Acad Sci U S A 1989
37
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia.
Michael Kalos, Bruce L Levine, David L Porter, Sharyn Katz, Stephan A Grupp, Adam Bagg, Carl H June. Sci Transl Med 2011
Michael Kalos, Bruce L Levine, David L Porter, Sharyn Katz, Stephan A Grupp, Adam Bagg, Carl H June. Sci Transl Med 2011
25
Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells.
Cameron J Turtle, Laïla-Aïcha Hanafi, Carolina Berger, Michael Hudecek, Barbara Pender, Emily Robinson, Reed Hawkins, Colette Chaney, Sindhu Cherian, Xueyan Chen,[...]. Sci Transl Med 2016
Cameron J Turtle, Laïla-Aïcha Hanafi, Carolina Berger, Michael Hudecek, Barbara Pender, Emily Robinson, Reed Hawkins, Colette Chaney, Sindhu Cherian, Xueyan Chen,[...]. Sci Transl Med 2016
25
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
Shannon L Maude, Theodore W Laetsch, Jochen Buechner, Susana Rives, Michael Boyer, Henrique Bittencourt, Peter Bader, Michael R Verneris, Heather E Stefanski, Gary D Myers,[...]. N Engl J Med 2018
Shannon L Maude, Theodore W Laetsch, Jochen Buechner, Susana Rives, Michael Boyer, Henrique Bittencourt, Peter Bader, Michael R Verneris, Heather E Stefanski, Gary D Myers,[...]. N Engl J Med 2018
25
Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells.
Juliane Gust, Kevin A Hay, Laïla-Aïcha Hanafi, Daniel Li, David Myerson, Luis F Gonzalez-Cuyar, Cecilia Yeung, W Conrad Liles, Mark Wurfel, Jose A Lopez,[...]. Cancer Discov 2017
Juliane Gust, Kevin A Hay, Laïla-Aïcha Hanafi, Daniel Li, David Myerson, Luis F Gonzalez-Cuyar, Cecilia Yeung, W Conrad Liles, Mark Wurfel, Jose A Lopez,[...]. Cancer Discov 2017
25
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells.
Omkar U Kawalekar, Roddy S O'Connor, Joseph A Fraietta, Lili Guo, Shannon E McGettigan, Avery D Posey, Prachi R Patel, Sonia Guedan, John Scholler, Brian Keith,[...]. Immunity 2016
Omkar U Kawalekar, Roddy S O'Connor, Joseph A Fraietta, Lili Guo, Shannon E McGettigan, Avery D Posey, Prachi R Patel, Sonia Guedan, John Scholler, Brian Keith,[...]. Immunity 2016
25
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
Daniel W Lee, Bianca D Santomasso, Frederick L Locke, Armin Ghobadi, Cameron J Turtle, Jennifer N Brudno, Marcela V Maus, Jae H Park, Elena Mead, Steven Pavletic,[...]. Biol Blood Marrow Transplant 2019
Daniel W Lee, Bianca D Santomasso, Frederick L Locke, Armin Ghobadi, Cameron J Turtle, Jennifer N Brudno, Marcela V Maus, Jae H Park, Elena Mead, Steven Pavletic,[...]. Biol Blood Marrow Transplant 2019
25
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.
Daniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, Yongzhi K Cui, Cindy Delbrook, Steven A Feldman, Terry J Fry, Rimas Orentas, Marianna Sabatino, Nirali N Shah,[...]. Lancet 2015
Daniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, Yongzhi K Cui, Cindy Delbrook, Steven A Feldman, Terry J Fry, Rimas Orentas, Marianna Sabatino, Nirali N Shah,[...]. Lancet 2015
25
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia.
David L Porter, Wei-Ting Hwang, Noelle V Frey, Simon F Lacey, Pamela A Shaw, Alison W Loren, Adam Bagg, Katherine T Marcucci, Angela Shen, Vanessa Gonzalez,[...]. Sci Transl Med 2015
David L Porter, Wei-Ting Hwang, Noelle V Frey, Simon F Lacey, Pamela A Shaw, Alison W Loren, Adam Bagg, Katherine T Marcucci, Angela Shen, Vanessa Gonzalez,[...]. Sci Transl Med 2015
25
Chimeric antigen receptor T cell persistence and memory cell formation.
Alexander D McLellan, Seyed M Ali Hosseini Rad. Immunol Cell Biol 2019
Alexander D McLellan, Seyed M Ali Hosseini Rad. Immunol Cell Biol 2019
25
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.
Jae H Park, Isabelle Rivière, Mithat Gonen, Xiuyan Wang, Brigitte Sénéchal, Kevin J Curran, Craig Sauter, Yongzeng Wang, Bianca Santomasso, Elena Mead,[...]. N Engl J Med 2018
Jae H Park, Isabelle Rivière, Mithat Gonen, Xiuyan Wang, Brigitte Sénéchal, Kevin J Curran, Craig Sauter, Yongzeng Wang, Bianca Santomasso, Elena Mead,[...]. N Engl J Med 2018
25
Clinical manufacturing of CAR T cells: foundation of a promising therapy.
Xiuyan Wang, Isabelle Rivière. Mol Ther Oncolytics 2016
Xiuyan Wang, Isabelle Rivière. Mol Ther Oncolytics 2016
25
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.
Joseph A Fraietta, Simon F Lacey, Elena J Orlando, Iulian Pruteanu-Malinici, Mercy Gohil, Stefan Lundh, Alina C Boesteanu, Yan Wang, Roddy S O'Connor, Wei-Ting Hwang,[...]. Nat Med 2018
Joseph A Fraietta, Simon F Lacey, Elena J Orlando, Iulian Pruteanu-Malinici, Mercy Gohil, Stefan Lundh, Alina C Boesteanu, Yan Wang, Roddy S O'Connor, Wei-Ting Hwang,[...]. Nat Med 2018
25
T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.
Jennifer N Brudno, Irina Maric, Steven D Hartman, Jeremy J Rose, Michael Wang, Norris Lam, Maryalice Stetler-Stevenson, Dalia Salem, Constance Yuan, Steven Pavletic,[...]. J Clin Oncol 2018
Jennifer N Brudno, Irina Maric, Steven D Hartman, Jeremy J Rose, Michael Wang, Norris Lam, Maryalice Stetler-Stevenson, Dalia Salem, Constance Yuan, Steven Pavletic,[...]. J Clin Oncol 2018
25
CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date.
Jae H Park, Mark B Geyer, Renier J Brentjens. Blood 2016
Jae H Park, Mark B Geyer, Renier J Brentjens. Blood 2016
25
CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients.
Cameron J Turtle, Laïla-Aïcha Hanafi, Carolina Berger, Theodore A Gooley, Sindhu Cherian, Michael Hudecek, Daniel Sommermeyer, Katherine Melville, Barbara Pender, Tanya M Budiarto,[...]. J Clin Invest 2016
Cameron J Turtle, Laïla-Aïcha Hanafi, Carolina Berger, Theodore A Gooley, Sindhu Cherian, Michael Hudecek, Daniel Sommermeyer, Katherine Melville, Barbara Pender, Tanya M Budiarto,[...]. J Clin Invest 2016
25
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
Sattva S Neelapu, Frederick L Locke, Nancy L Bartlett, Lazaros J Lekakis, David B Miklos, Caron A Jacobson, Ira Braunschweig, Olalekan O Oluwole, Tanya Siddiqi, Yi Lin,[...]. N Engl J Med 2017
Sattva S Neelapu, Frederick L Locke, Nancy L Bartlett, Lazaros J Lekakis, David B Miklos, Caron A Jacobson, Ira Braunschweig, Olalekan O Oluwole, Tanya Siddiqi, Yi Lin,[...]. N Engl J Med 2017
25
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Stephen J Schuster, Michael R Bishop, Constantine S Tam, Edmund K Waller, Peter Borchmann, Joseph P McGuirk, Ulrich Jäger, Samantha Jaglowski, Charalambos Andreadis, Jason R Westin,[...]. N Engl J Med 2019
Stephen J Schuster, Michael R Bishop, Constantine S Tam, Edmund K Waller, Peter Borchmann, Joseph P McGuirk, Ulrich Jäger, Samantha Jaglowski, Charalambos Andreadis, Jason R Westin,[...]. N Engl J Med 2019
25
Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-Analysis.
Emma J M Grigor, Dean Fergusson, Natasha Kekre, Joshua Montroy, Harold Atkins, Matthew D Seftel, Mads Daugaard, Justin Presseau, Kednapa Thavorn, Brian Hutton,[...]. Transfus Med Rev 2019
Emma J M Grigor, Dean Fergusson, Natasha Kekre, Joshua Montroy, Harold Atkins, Matthew D Seftel, Mads Daugaard, Justin Presseau, Kednapa Thavorn, Brian Hutton,[...]. Transfus Med Rev 2019
25
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.
Sattva S Neelapu, Sudhakar Tummala, Partow Kebriaei, William Wierda, Cristina Gutierrez, Frederick L Locke, Krishna V Komanduri, Yi Lin, Nitin Jain, Naval Daver,[...]. Nat Rev Clin Oncol 2018
Sattva S Neelapu, Sudhakar Tummala, Partow Kebriaei, William Wierda, Cristina Gutierrez, Frederick L Locke, Krishna V Komanduri, Yi Lin, Nitin Jain, Naval Daver,[...]. Nat Rev Clin Oncol 2018
25
Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology.
Keisuke Watanabe, Shunichiro Kuramitsu, Avery D Posey, Carl H June. Front Immunol 2018
Keisuke Watanabe, Shunichiro Kuramitsu, Avery D Posey, Carl H June. Front Immunol 2018
25
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells.
Margherita Norelli, Barbara Camisa, Giulia Barbiera, Laura Falcone, Ayurzana Purevdorj, Marco Genua, Francesca Sanvito, Maurilio Ponzoni, Claudio Doglioni, Patrizia Cristofori,[...]. Nat Med 2018
Margherita Norelli, Barbara Camisa, Giulia Barbiera, Laura Falcone, Ayurzana Purevdorj, Marco Genua, Francesca Sanvito, Maurilio Ponzoni, Claudio Doglioni, Patrizia Cristofori,[...]. Nat Med 2018
25
A guide to manufacturing CAR T cell therapies.
Philipp Vormittag, Rebecca Gunn, Sara Ghorashian, Farlan S Veraitch. Curr Opin Biotechnol 2018
Philipp Vormittag, Rebecca Gunn, Sara Ghorashian, Farlan S Veraitch. Curr Opin Biotechnol 2018
25
Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts.
Jessica Hartmann, Martina Schüßler-Lenz, Attilio Bondanza, Christian J Buchholz. EMBO Mol Med 2017
Jessica Hartmann, Martina Schüßler-Lenz, Attilio Bondanza, Christian J Buchholz. EMBO Mol Med 2017
25
Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.
Stephan A Grupp, Michael Kalos, David Barrett, Richard Aplenc, David L Porter, Susan R Rheingold, David T Teachey, Anne Chew, Bernd Hauck, J Fraser Wright,[...]. N Engl J Med 2013
Stephan A Grupp, Michael Kalos, David Barrett, Richard Aplenc, David L Porter, Susan R Rheingold, David T Teachey, Anne Chew, Bernd Hauck, J Fraser Wright,[...]. N Engl J Med 2013
25
Chimeric antigen receptor T cell therapy in oncology - Pipeline at a glance: Analysis of the ClinicalTrials.gov database.
E Moreno-Cortes, J V Forero-Forero, P A Lengerke-Diaz, J E Castro. Crit Rev Oncol Hematol 2021
E Moreno-Cortes, J V Forero-Forero, P A Lengerke-Diaz, J E Castro. Crit Rev Oncol Hematol 2021
25
Global Manufacturing of CAR T Cell Therapy.
Bruce L Levine, James Miskin, Keith Wonnacott, Christopher Keir. Mol Ther Methods Clin Dev 2016
Bruce L Levine, James Miskin, Keith Wonnacott, Christopher Keir. Mol Ther Methods Clin Dev 2016
25
Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia.
Noelle V Frey, Saar Gill, Elizabeth O Hexner, Stephen Schuster, Sunita Nasta, Alison Loren, Jakub Svoboda, Edward Stadtmauer, Daniel J Landsburg, Anthony Mato,[...]. J Clin Oncol 2020
Noelle V Frey, Saar Gill, Elizabeth O Hexner, Stephen Schuster, Sunita Nasta, Alison Loren, Jakub Svoboda, Edward Stadtmauer, Daniel J Landsburg, Anthony Mato,[...]. J Clin Oncol 2020
25
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
Stephen J Schuster, Constantine S Tam, Peter Borchmann, Nina Worel, Joseph P McGuirk, Harald Holte, Edmund K Waller, Samantha Jaglowski, Michael R Bishop, Lloyd E Damon,[...]. Lancet Oncol 2021
Stephen J Schuster, Constantine S Tam, Peter Borchmann, Nina Worel, Joseph P McGuirk, Harald Holte, Edmund K Waller, Samantha Jaglowski, Michael R Bishop, Lloyd E Damon,[...]. Lancet Oncol 2021
25
Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma.
Chelsea C Pinnix, Jillian R Gunther, Bouthaina S Dabaja, Paolo Strati, Penny Fang, Misha C Hawkins, Sherry Adkins, Jason Westin, Sairah Ahmed, Luis Fayad,[...]. Blood Adv 2020
Chelsea C Pinnix, Jillian R Gunther, Bouthaina S Dabaja, Paolo Strati, Penny Fang, Misha C Hawkins, Sherry Adkins, Jason Westin, Sairah Ahmed, Luis Fayad,[...]. Blood Adv 2020
25
Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma.
Frederick L Locke, John M Rossi, Sattva S Neelapu, Caron A Jacobson, David B Miklos, Armin Ghobadi, Olalekan O Oluwole, Patrick M Reagan, Lazaros J Lekakis, Yi Lin,[...]. Blood Adv 2020
Frederick L Locke, John M Rossi, Sattva S Neelapu, Caron A Jacobson, David B Miklos, Armin Ghobadi, Olalekan O Oluwole, Patrick M Reagan, Lazaros J Lekakis, Yi Lin,[...]. Blood Adv 2020
25
CAR-T design: Elements and their synergistic function.
Jayapriya Jayaraman, Michael P Mellody, Andrew J Hou, Ruchi P Desai, Audrey W Fung, An Huynh Thuy Pham, Yvonne Y Chen, Weian Zhao. EBioMedicine 2020
Jayapriya Jayaraman, Michael P Mellody, Andrew J Hou, Ruchi P Desai, Audrey W Fung, An Huynh Thuy Pham, Yvonne Y Chen, Weian Zhao. EBioMedicine 2020
25
Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2.
Richard A Morgan, James C Yang, Mio Kitano, Mark E Dudley, Carolyn M Laurencot, Steven A Rosenberg. Mol Ther 2010
Richard A Morgan, James C Yang, Mio Kitano, Mark E Dudley, Carolyn M Laurencot, Steven A Rosenberg. Mol Ther 2010
25
Scalable Manufacturing of CAR T cells for Cancer Immunotherapy.
Mohamed Abou-El-Enein, Magdi Elsallab, Steven A Feldman, Andrew D Fesnak, Helen E Heslop, Peter Marks, Brian G Till, Gerhard Bauer, Barbara Savoldo. Blood Cancer Discov 2021
Mohamed Abou-El-Enein, Magdi Elsallab, Steven A Feldman, Andrew D Fesnak, Helen E Heslop, Peter Marks, Brian G Till, Gerhard Bauer, Barbara Savoldo. Blood Cancer Discov 2021
25
Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling.
Evan W Weber, Kevin R Parker, Elena Sotillo, Rachel C Lynn, Hima Anbunathan, John Lattin, Zinaida Good, Julia A Belk, Bence Daniel, Dorota Klysz,[...]. Science 2021
Evan W Weber, Kevin R Parker, Elena Sotillo, Rachel C Lynn, Hima Anbunathan, John Lattin, Zinaida Good, Julia A Belk, Bence Daniel, Dorota Klysz,[...]. Science 2021
25
A human memory T cell subset with stem cell-like properties.
Luca Gattinoni, Enrico Lugli, Yun Ji, Zoltan Pos, Chrystal M Paulos, Máire F Quigley, Jorge R Almeida, Emma Gostick, Zhiya Yu, Carmine Carpenito,[...]. Nat Med 2011
Luca Gattinoni, Enrico Lugli, Yun Ji, Zoltan Pos, Chrystal M Paulos, Máire F Quigley, Jorge R Almeida, Emma Gostick, Zhiya Yu, Carmine Carpenito,[...]. Nat Med 2011
25
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection.
Justin Eyquem, Jorge Mansilla-Soto, Theodoros Giavridis, Sjoukje J C van der Stegen, Mohamad Hamieh, Kristen M Cunanan, Ashlesha Odak, Mithat Gönen, Michel Sadelain. Nature 2017
Justin Eyquem, Jorge Mansilla-Soto, Theodoros Giavridis, Sjoukje J C van der Stegen, Mohamad Hamieh, Kristen M Cunanan, Ashlesha Odak, Mithat Gönen, Michel Sadelain. Nature 2017
25
CAR T Cell Toxicity: Current Management and Future Directions.
Lucrecia Yáñez, Miriam Sánchez-Escamilla, Miguel-Angel Perales. Hemasphere 2019
Lucrecia Yáñez, Miriam Sánchez-Escamilla, Miguel-Angel Perales. Hemasphere 2019
25
FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia.
Maura C O'Leary, Xiaobin Lu, Ying Huang, Xue Lin, Iftekhar Mahmood, Donna Przepiorka, Denise Gavin, Shiowjen Lee, Ke Liu, Bindu George,[...]. Clin Cancer Res 2019
Maura C O'Leary, Xiaobin Lu, Ying Huang, Xue Lin, Iftekhar Mahmood, Donna Przepiorka, Denise Gavin, Shiowjen Lee, Ke Liu, Bindu George,[...]. Clin Cancer Res 2019
25
Current concepts in the diagnosis and management of cytokine release syndrome.
Daniel W Lee, Rebecca Gardner, David L Porter, Chrystal U Louis, Nabil Ahmed, Michael Jensen, Stephan A Grupp, Crystal L Mackall. Blood 2014
Daniel W Lee, Rebecca Gardner, David L Porter, Chrystal U Louis, Nabil Ahmed, Michael Jensen, Stephan A Grupp, Crystal L Mackall. Blood 2014
25
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.
Bijal D Shah, Armin Ghobadi, Olalekan O Oluwole, Aaron C Logan, Nicolas Boissel, Ryan D Cassaday, Thibaut Leguay, Michael R Bishop, Max S Topp, Dimitrios Tzachanis,[...]. Lancet 2021
Bijal D Shah, Armin Ghobadi, Olalekan O Oluwole, Aaron C Logan, Nicolas Boissel, Ryan D Cassaday, Thibaut Leguay, Michael R Bishop, Max S Topp, Dimitrios Tzachanis,[...]. Lancet 2021
25
Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels.
James N Kochenderfer, Robert P T Somerville, Tangying Lu, Victoria Shi, Adrian Bot, John Rossi, Allen Xue, Stephanie L Goff, James C Yang, Richard M Sherry,[...]. J Clin Oncol 2017
James N Kochenderfer, Robert P T Somerville, Tangying Lu, Victoria Shi, Adrian Bot, John Rossi, Allen Xue, Stephanie L Goff, James C Yang, Richard M Sherry,[...]. J Clin Oncol 2017
12
Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies.
Harjeet Singh, Matthew J Figliola, Margaret J Dawson, Helen Huls, Simon Olivares, Kirsten Switzer, Tiejuan Mi, Sourindra Maiti, Partow Kebriaei, Dean A Lee,[...]. Cancer Res 2011
Harjeet Singh, Matthew J Figliola, Margaret J Dawson, Helen Huls, Simon Olivares, Kirsten Switzer, Tiejuan Mi, Sourindra Maiti, Partow Kebriaei, Dean A Lee,[...]. Cancer Res 2011
12
Chimeric antigen receptor T cells for sustained remissions in leukemia.
Shannon L Maude, Noelle Frey, Pamela A Shaw, Richard Aplenc, David M Barrett, Nancy J Bunin, Anne Chew, Vanessa E Gonzalez, Zhaohui Zheng, Simon F Lacey,[...]. N Engl J Med 2014
Shannon L Maude, Noelle Frey, Pamela A Shaw, Richard Aplenc, David M Barrett, Nancy J Bunin, Anne Chew, Vanessa E Gonzalez, Zhaohui Zheng, Simon F Lacey,[...]. N Engl J Med 2014
12
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells.
Christopher A Klebanoff, Steven E Finkelstein, Deborah R Surman, Michael K Lichtman, Luca Gattinoni, Marc R Theoret, Navrose Grewal, Paul J Spiess, Paul A Antony, Douglas C Palmer,[...]. Proc Natl Acad Sci U S A 2004
Christopher A Klebanoff, Steven E Finkelstein, Deborah R Surman, Michael K Lichtman, Luca Gattinoni, Marc R Theoret, Navrose Grewal, Paul J Spiess, Paul A Antony, Douglas C Palmer,[...]. Proc Natl Acad Sci U S A 2004
12
Blockade of PD-1 immunosuppression boosts CAR T-cell therapy.
Liza B John, Michael H Kershaw, Phillip K Darcy. Oncoimmunology 2013
Liza B John, Michael H Kershaw, Phillip K Darcy. Oncoimmunology 2013
12
In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas.
Carlos A Ramos, Rayne Rouce, Catherine S Robertson, Amy Reyna, Neeharika Narala, Gayatri Vyas, Birju Mehta, Huimin Zhang, Olga Dakhova, George Carrum,[...]. Mol Ther 2018
Carlos A Ramos, Rayne Rouce, Catherine S Robertson, Amy Reyna, Neeharika Narala, Gayatri Vyas, Birju Mehta, Huimin Zhang, Olga Dakhova, George Carrum,[...]. Mol Ther 2018
12
CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.
Claudia M Kowolik, Max S Topp, Sergio Gonzalez, Timothy Pfeiffer, Simon Olivares, Nancy Gonzalez, David D Smith, Stephen J Forman, Michael C Jensen, Laurence J N Cooper. Cancer Res 2006
Claudia M Kowolik, Max S Topp, Sergio Gonzalez, Timothy Pfeiffer, Simon Olivares, Nancy Gonzalez, David D Smith, Stephen J Forman, Michael C Jensen, Laurence J N Cooper. Cancer Res 2006
12
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias.
Renier J Brentjens, Isabelle Rivière, Jae H Park, Marco L Davila, Xiuyan Wang, Jolanta Stefanski, Clare Taylor, Raymond Yeh, Shirley Bartido, Oriana Borquez-Ojeda,[...]. Blood 2011
Renier J Brentjens, Isabelle Rivière, Jae H Park, Marco L Davila, Xiuyan Wang, Jolanta Stefanski, Clare Taylor, Raymond Yeh, Shirley Bartido, Oriana Borquez-Ojeda,[...]. Blood 2011
12
Target selection of CAR T cell therapy in accordance with the TME for solid tumors.
Bainan Liu, Lingli Yan, Ming Zhou. Am J Cancer Res 2019
Bainan Liu, Lingli Yan, Ming Zhou. Am J Cancer Res 2019
12
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.